From new technologies to awareness campaigns, the radiology industry has taken great strides to address concerns about radiation dose. Is it enough?
From adopting new technologies to updating protocols, the radiology industry has taken great strides in recent years to address concerns about radiation dose. Imaging professionals are pledging to increase awareness among peers and patients, and a recent study even examines the possibility of an antioxidant pill protecting patients from radiation-induced cancer.
Is the industry doing enough to reduce dose? What else can be done?
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Approves New PSMA PET Agent POSLUMA for Prostate Cancer Imaging
May 30th 2023Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level.
2 Clarke Drive
Cranbury, NJ 08512